According to him, the company plans to start production of vaccines before the end of this year, although earlier it was planned to deploy the release only by 2021. Johnson & Johnson will allocate more than a billion dollars to develop the vaccine.
Earlier in the city of Seattle (Washington), for the first time, they introduced the experimental vaccine against coronavirus to a healthy person – 44-year-old American Jennifer Haller.
Italian scientists have reported the creation of a prototype vaccine that can neutralize SARS-CoV-2. Its effectiveness was confirmed by experiments on laboratory mice. People testing is about to begin in the fall of 2020. However, in other countries, this message was perceived with skepticism.
At the moment, the number of patients with coronavirus in the world has exceeded 4.2 million. This is evidenced by the data of Johns Hopkins University.